摘要
MicroRNAs (miRNAs) 是一种长度为19-25个核苷酸组成的小的非编码RNAs,可以作为基因负转录调节器。MiRNAs 混合生成了靶mRNAs的3’非编码区(UTR),并且抑制翻译或调解 mRNA cleavage 裂解。MiRNAs主要通过致癌、肿瘤抑制靶基因或基因相关的增殖、血管生成和细胞凋亡,调解肿瘤发生和恶化。不同的肿瘤类型和不同阶段的肿瘤具有独特的miRNA表达谱。MiRNAs 作为癌症诊断、演进和治疗反应的潜在生物靶点很有希望。对miRNA促进骨转移方面的作用进行了研究。我们对有关miRNA调节乳腺癌、前列腺癌、肺癌和 多发性骨髓癌转移性扩散的机制的近期发现进行了总结。我们总结了miRNA表达谱的异同点,也许可以解释不同种类癌转移性扩散至骨骼的多种分子通路。 最后,从近期临床前和临床研究数据方面,我们讨论了miRNAs作为诊断和治疗靶点的令人振奋的潜能,以便减少癌症骨转移的风险。
关键词: 骨转移,乳腺癌,肺癌,microRNA,多发性骨髓瘤,前列腺癌
图形摘要
Current Cancer Drug Targets
Title:Bone Metastasis-Related MicroRNAs: New Targets for Treatment?
Volume: 15 Issue: 8
Author(s): Qian Zhao, Fengming Luo, Junrong Ma and Xijie Yu
Affiliation:
关键词: 骨转移,乳腺癌,肺癌,microRNA,多发性骨髓瘤,前列腺癌
摘要: MicroRNAs (miRNAs) are a new class of small noncoding RNAs of 19–25 nucleotides that function as negative posttranscriptional gene regulators. MiRNAs hybridize to the 3’ untranslated region (UTR) of target mRNAs and repress translation or mediate mRNA cleavage. MiRNAs critically regulate tumorigenesis and progression by targeting oncogenes, tumor suppressor genes, or genes related to proliferation, angiogenesis, and apoptosis. Different tumor types and tumors at different stages exhibit unique miRNA profiles. MiRNAs show promise as potential biomarkers for cancer diagnostics, progression, and response to treatment. The role of miRNAs in promoting bone metastases is under investigated. We summarize recent findings on the mechanisms by which miRNAs may regulate bone metastatic spread of breast cancer, prostate cancer,lung cancer and multiple myeloma. We review similarities and differences in miRNA profiles that may explain the variety of molecular pathways underling metastatic spread to the skeleton in different cancers. Finally, we discuss the exciting potential of using miRNAs as diagnostics and therapeutic targets to reduce the risk of bone metastases in cancer, from the perspective of data provided by recent pre-clinical and clinical studies.
Export Options
About this article
Cite this article as:
Qian Zhao, Fengming Luo, Junrong Ma and Xijie Yu , Bone Metastasis-Related MicroRNAs: New Targets for Treatment?, Current Cancer Drug Targets 2015; 15 (8) . https://dx.doi.org/10.2174/1568009615666150629102408
DOI https://dx.doi.org/10.2174/1568009615666150629102408 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structure Based Drug Design and Molecular Docking Studies of Anticancer Molecules Paclitaxel, Etoposide and Topotecan using Novel Ligands
Current Drug Discovery Technologies The Synthesis and Evaluation of Novel Lactate Dehydrogenase Nanobioconjugates
Current Nanoscience Doxorubicin: The Good, the Bad and the Ugly Effect
Current Medicinal Chemistry Patent Selections
Recent Patents on DNA & Gene Sequences Body Mass Index, Lipid Metabolism and Estrogens: Their Impact on Coronary Heart Disease
Current Medicinal Chemistry Dequalinium-Derived Nanoconstructs: A Promising Vehicle for Mitochondrial Targeting
Current Drug Delivery HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Application of Carbon Nanomaterials in Gene Delivery for Endogenous RNA Interference <i>In Vitro</i> and <i>In Vivo</i>
Current Pharmaceutical Design SENP1 as A Biomarker for the Diagnosis of Cancer: Review of the Science and Published Patents
Recent Patents on Biomarkers Pharmacokinetic and Toxicological Characteristics of Tripterigium Glycosides and Their Derivatives
Current Drug Metabolism Production, Purification and Characterization of Adeno-Associated Vectors
Current Gene Therapy Metastasis-Inducing S100A4 Protein: Implication in Non-Malignant Human Pathologies
Current Molecular Medicine microRNAs: Small Molecules with a Potentially Role in Oral Squamous Cell Carcinoma
Current Pharmaceutical Design Preface: Studies on Understanding and Anti-Tumor Agents of Reproductive Cancer Cells
Current Pharmaceutical Biotechnology Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis
CNS & Neurological Disorders - Drug Targets Preface: MicroRNA as Disease Biomarkers
MicroRNA Modulation of intracellular pH in human ovarian cancer.
Current Molecular Medicine Endothelial Expression of MHC Class II Molecules in Autoimmune Disease
Current Pharmaceutical Design Current State of Development of Genome Analysis in Livestock
Current Genomics Histone Deacetylase Inhibitors: A Review on Class-I Specific Inhibition
Mini-Reviews in Medicinal Chemistry